| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.078 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |